| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $246.8M | +18.6% |
| Cost of Revenue | $70.8M | +18.3% |
| Gross Profit | $176.0M | +18.7% |
| R&D Expense | $7.1M | +25.3% |
| SG&A Expense | $60.8M | +7.0% |
| Operating Income | -$12.8M | -624.1% |
| Pre-tax Income | -$15.5M | -574.8% |
| Income Tax | $2.4M | -74.9% |
| Net Income | -$17.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.9M | -22.3% |
| Accounts Receivable | $54.8M | +10.8% |
| Inventory | $23.1M | +20.3% |
| Current Assets | $119.8M | +5.5% |
| Total Assets | $255.0M | +4.4% |
| Current Liabilities | $64.3M | +86.7% |
| Total Liabilities | $133.6M | +15.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.2M | +98.0% |
| Capital Expenditures | $1.8M | -15.4% |
| Investing Cash Flow | -$1.9M | +97.7% |
| Financing Cash Flow | -$9.6M | -116.0% |
| Free Cash Flow | $3.4M | +549.4% |
| -51.3% |
| EPS (Basic) | -$0.89 | -48.3% |
| EPS (Diluted) | -$0.89 | -48.3% |
| Stockholders' Equity |
| $121.4M |
| -5.3% |